Engagement of CD28 outside of the immunological synapse results in up-regulation of IL-2 mRNA stability but not IL-2 transcription

Journal of Immunology

Volumn 176, Issue 8, 2006, Pages 4778-4784

  Sanchez Lockhart, Mariano ^a   Miller, Jim ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CELL PROTEIN; CENTRAL SUPRAMOLECULAR ACTIVATION CLUSTER PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C THETA; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAFT REJECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RNA STABILITY; SIGNAL PROCESSING; SIGNAL TRANSDUCTION; SYNAPSE; T LYMPHOCYTE ACTIVATION;

EID: 33645787258     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.8.4778     Document Type: Article

References (74)

1. Acuto, O., and F. Michel. 2003. CD28-mediated co-stimulation: a quantitative support for TCR signaling. Nat. Rev. Immunol. 3: 939-951.
2. Lenschow, D., T. Walunas, and J. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14: 233-258.
3. Rudd, C. E. 1996. Upstream-downstream: CD28 cosignaling pathways and T cell function. Immunity 4: 527-534.
4. Rudd, C. E., and H. Schneider. 2003. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 3: 544-556.
5. Harding, F., J. McArthur, J. Gross, D. Raulet, and J. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356: 607-609.
6. Jenkins, M., C. Chen, G. Jung, D. Mueller, and R. Schwartz. 1990. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144: 16-22.
7. Fraser, J., B. Irving, G. Crabtree, and A. Weiss. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 25): 313-316.
8. Lindsten, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244: 339-343.
9. L. Immunity 3: 87-98.
10. Frauwirth, K., J. Riley, M. Harris, R. Parry, J. Rathmell, D. Plas, R. Elstrom, C. June, and C. Thompson. 2002. The CD28 signalling pathway regulates glucose metabolism. Immunity 16: 769-777.
11. Rulifson, I., A. Sperling, P. Fields, F. Fitch, and J. Bluestone. 1997. CD28 Costimulation promotes the production of Th2 cytokines. J. Immunol. 158: 658-665.
12. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273: 104-106.
13. Michel, F., G. Attal-Bonnefoy, G. Mangino, S. Mise-Omata, and O. Acuto. 2002. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity 15: 935-945.
14. Diehn, M., A. Alizadeh, O. Rando, C. Liu, K. Stankunas, D. Botstein, G. Crabtree, and P. Brown. 2002. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc. Natl. Acad. Sci. USA 99: 11796-11801.
15. Riley, J., M. Mao, S. Kobayashi, M. Biery, J. Burchard, G. Cavet, B. Gregson, C. June, and P. Linsley. 2002. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl. Acad. Sci. USA 99: 11790-11795.
16. Bromley, S. K., W. R. Burack, K. G. Johnson, K. Somersalo, T. N. Sims, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin. 2001. The immunological synapse. Annu. Rev. Immunol. 19: 375-396.
17. Dustin, M. L., and A. C. Chan. 2000. Signaling takes shape in the immune system. Cell 103: 283-294.
18. Huppa, J., and M. Davis. 2003. T-cell-antigen recognition and the immunological synapse. Nat. Rev. Immunol. 3: 973-983.
19. van der Merwe, P. A. 2002. Formation and function of the immunological synapse. Curr. Opin. Immunol. 14: 293-298.
20. Bromley, S., A. Iaboni, S. Davis, A. Whitty, J. Green, A. Shaw, A. Weiss, and M. Dustin. 2001. The immunological synapse and CD28-CD80 interactions. Nat. Immunol. 2: 1159-1166.
21. Monks, C., H. Kupfer, I. Tamir, A. Barlow, and A. Kupfer. 1997. Selective modulation of protein kinase C-θ during T cell activation. Nature 385: 83-86.
22. Altman, A., N. Isakov, and G. Baier. 2000. Protein kinase Cθ: a new essential superstar on the T-cell stage. Immunol. Today 21: 567-573.
23. Lee, K. Y., F. D'Acquisto, M. S. Hayden, J. H. Shim, and S. Ghosh. 2005. PDK1 nucleates T cell receptor-induced signaling complex for NF-κB activation. Science 308: 114-118.
24. Sun, Z., C. W. Arendt, W. Ellmeier, E. M. Schaeffer, M. J. Sunshine, L. Gandhi, J. Annes, D. Petrzilka, A. Kupfer, P. L. Schwartzberg, and D. R. Littman. 2000. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404: 402-407.
25. Huang, J., P. Lo, T. Zal, N. Gascoigne, B. Smith, S. Levin, and H. Grey. 2002. CD28 plays a critical role in the segregation of PKC9 within the immunological synapse. Proc. Natl. Acad. Sci. USA 99: 9369-9373.
26. Sanchez-Lockhart, M., E. Marin, B. Graf, R. Abe, Y. Harada, C. E. Sedwick, and J. Miller. 2004. Cutting edge: CD28-mediated transcriptional and posttranscriptional regulation of 1L-2 expression are controlled through different signaling pathways. J Immunol. 173: 7120-7124.
27. Costello, P., M. Gallagher, and D. Cantrell. 2002. Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse. Nat. Immunol 3: 1082-1089.
28. Harriague, J., and G. Bismuth. 2002. Imaging antigen-induced PI3K activation in T cells. Nat. Immunol. 3: 1090-1096.
29. Huppa, J., M. Gleimer, C. Sumen, and M. Davis. 2003. Continuous T cell receptor signaling required for synapse maintenance and full effector potential. Nat. Immunol. 4: 749-755.
30. Jenkins, M. K., I. D. Ashwell, and R. H. Schwartz. 1988. Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells. J. Immunol. 140: 3324-3330.
31. + T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation). Eur. J. Immunol. 24: 859-866.
32. Reiser, H., G. J. Freeman, Z. Razi-Wolf, C. D. Gimmi, B. Benacerraf, and L. M. Nadler. 1992. Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex. Proc. Natl. Acad. Sci. USA 89: 271-275.
33. + T lymphocytes in HLA-restricted reactions: implications for immune augmentation cancer therapy and autoimmunity. J. Immunol. 163: 3239-3249.
34. Mandelbrot, D. A., K. Kishimoto, H. Auchincloss, Jr., A. H. Sharpe, and M. H. Sayegh. 2001. Rejection of mouse cardiac allografts by costimulation in trans. J. Immunol. 167: 1174-1178.
35. Zuckerman, L., L. Pullen, and J. Miller, 1998. Functional consequences of costimulation by ICAM-1 on IL-2 gene expression and T cell activation. J. Immunol. 160: 3259-3268.
36. Razi-Wolf, Z., G. Freeman, F. Galvin, B. Benacerraf, L. Nadler, and H. Reiser. 1992. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc. Natl. Acad. Sci. USA 89: 4210-4214.
37. Abraham, C., and J. Miller. 2001. Molecular mechanisms of IL-2 gene regulation following costimulation through LFA-1. J. Immunol. 167: 5193-5201.
38. Brunner, M. C., C. Chambers, F. Chan, J. Hanke, A. Winoto, and J. Allison. 1999. CTLA-4-mediated inhibition of early events of T cell proliferation. J. Immunol. 162: 5813-5820.
39. Tam, W. F., L. H. Lee, L. Davis, and R. Sen. 2000. Cytoplasmic sequestration of rel proteins by IκBα requires CRM1-dependent nuclear export. Mol. Cell. Biol. 20: 2269-2284.
40. Garcia-Sanz, J. A., and D. Lenig. 1996. Translational control of interleuldn 2 messenger RNA as a molecular mechanism of T cell anergy. J. Exp. Med. 184: 159-164.
41. Long, A., D. Kelleher, S. Lynch, and Y. Volkov. 2001. Cutting edge: protein kinase C(3 expression is critical for export of IL-2 from T cells. J. Immunol. 167: 636-640.
42. Umlauf, S., B. Beverly, O. Lantz, and R. Schwartz. 1995. Regulation of interleukin 2 gene expression by CD28 costimulation in mouse T-cell clones: both nuclear and cytoplasmic RNAs are regulated with complex kinetics. Mol. Cell. Biol. 15:3197-3205.
43. Ledbetter, J. A., J. B. Imboden, G. L. Schieven, L. S. Grosmaire, P. S. Rabinovitch, T. Lindsten, C. B. Thompson, and C. H. June. 1990. CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood 75: 1531-1539.
44. Ledbetter, J. A., C. H. June, L. S. Grosmaire, and P. S. Rabinovitch. 1987. Crosslinking of surface antigens causes mobilization of intracellular ionized calcium in T lymphocytes. Proc. Natl. Acad. Sci. USA 84: 1384-1388.
45. Raab, M., S. Pfister, and C. E. Rudd. 2001. CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation. Immunity 15: 921-933.
46. Evans, E. J., R. M. Esnouf, R. Manso-Sancho, R. J. Gilbert, J. R. James, C. Yu, J. A. Fennelly, C. Vowles, T. Hanke, B. Walse, et al. 2005. Crystal structure of a soluble CD28-Fab complex. Nat. Immunol. 6: 271-279.
47. Lühder, F., Y. Huang, K. M. Dennehy, C. Guntermann, I. Müller, E. Winkler, T. Kerkau, S. Ikemizu, S. J. Davis, T. Hanke, and T. Hünig. 2003. Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists. J. Exp. Med. 197: 955-966.
48. Dennehy, K. M., A. Kerstan, A. Bischof, J. H. Park, S. Y. Na, and T. Hünig. 2003. Mitogenic signals through CD28 activate the protein kinase Coθ-NF-κB pathway in primary peripheral T cells. Int. Immunol. 15: 655-663.
49. Bischof, A., T. Hara, C. H. Lin, A. D. Beyers, and T. Hünig. 2000. Autonomous induction of proliferation, JNK and NF-κB activation in primary resting T cells by mobilized CD28. Eur. J. Immunol. 30: 876-882.
50. Holdorf, A. D., J. M. Green, S. D. Levin, M. F. Denny, D. B. Straus, V. Link, P. S. Changelian, P. M. Allen, and A. S. Shaw. 1999. Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation. J. Exp. Med. 190: 375-384.
51. Tavano, R., G. Gri, B. Molon, B. Marinari, C. E. Rudd, L. Tuosto, and A. Viola. 2004. CD28 and lipid rafts coordinate recruitment of Lck to the immunological synapse of human T lymphocytes. J. Immunol. 173: 5392-5397.
52. Raghavan, A., M. Dhalla, T. Bakheet, R. L. Ogilvie, I. A. Vlasova, K. S. Khabar, B. R. Williams, and P. R. Bohjanen. 2004. Patterns of coordinate down-regulation of ARE-containing transcripts following immune cell activation. Genomics 84: 1002-1013.
53. Raghavan, A., R. L. Ogilvie, C. Reilly, M. L. Abelson, S. Raghavan, J. Vasdewani, M. Krathwohl, and P. R. Bohjanen. 2002. Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes. Nucleic Acids Res. 30: 5529-5538.
54. Kracht, M., and J. Saklatvala. 2002. Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine 20: 91-106.
55. Shim, J., and M. Karin. 2002. The control of mRNA stability in response to extracellular signals. Mol. Cells 14: 323-331.
56. Carbello, E., W. Lai, and P. Blackshear. 1998. Feedback inhibition of macrophage tumor necrosis factor-α production by tristertraprolin. Science 281: 1001-1005.
57. Kontoyiannis, D., M. Pasparakis, T. T. Pizarro, F. Cominelli, and G. Kollias. 1999. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10: 387-398.
58. Ogilvie, R. L., M. Abelson, H. H. Hau, I. Vlasova, P. J. Blackshear, and P. R. Bohjanen. 2005. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J. Immunol. 174: 953-961.
59. Raghavan, A., R. Robinson, J. McNabb, C. Miller, D. Williams, and P. Bohjanen. 2001. HuA and tristetraprolin are induced following T cell activation and display distinct overlapping RNA binding specificities. J. Biol. Chem. 276: 47958-47965.
60. Shim, J., H. Lim, J. Yates, and K. M. 2002. Nuclear export of NF90 is required for interleukin-2 mRNA stabilization. Mol. Cell 10: 1331-1344.
61. Brennan, C. M., I. Gallouzi, and J. Steitz. 2000. Protein ligands to HuR modulate its interaction with target mRNAs in vivo. J. Cell Biol. 151: 1-14.
62. Chen, C. Y., F. Del Gatto-Konczak, Z. Wu, and M. Karin. 1998. Stabilization of IL-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 280: 1945-1949.
63. Chen, C. Y., R. Gherzi, J. Andersen, G. Gaietta, K. Jurchott, H. Royer, M. Mann, and M. Karin. 2000. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev. 14: 1236-1248.
64. Ming, X. F., M. Kaiser, and C. Moroni. 1998. c-jun N-terminal kinase is involved in AUUUA-mediated IL-3 mRNA turnover in mast cells. EMBO J. 17: 6039-6048.
65. Mahtani, K., M. Brook, J. Dean, G. Sully, J. Saklatvala, and A. Clark. 2001. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor α mRNA stability. Mol. Cell Biol. 21: 6461-6469.
66. Mestas, J., S. P. Crampton, T. Hori, and C. C. Hughes. 2005. Endothelial cell co-stimulation through OX40 augments and prolongs T cell cytokine synthesis by stabilization of cytokine mRNA. Int. Immunol. 17: 737-747.
67. Winzen, R., M. Kracht, B. Ritter, A. Wilheim, C. Chen, A. Shyu, M. Muller, M. Gaestel, K. Resch, and H. Holtmann. 1999. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase activated protein kinase-2 and an AU-rich region-targeted mechanism. EMBO J. 18: 4969-4980.
68. Wilson, G., J. Lu, K. Sutphen, Y. Sun, Y. Huynh, and G. Brewer. 2003. Regulation of AU-rich element directed mRNA turnover involving reversible phosphorylation of AUF1. J. Biol. Chem. 278: 33029-33038.
69. Andres, P., K. Howland, A. Nirula, L. Kane, L. Barron, D. Dresnek, A. Sadra, J. Imboden, A. Weiss, and A. Abbas. 2004. Distinct regions in the CD28 cytoplasmic domain are required for T helper type 2 differentiation. Nat. Immunol. 5: 435-442.
70. Tai, X., M. Cowan, L. Feigenbaum, and A. Singer. 2005. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6: 152-162.
71. L. J. Immunol. 166: 5331-5335.
72. Harada, Y., M. Tokushima, Y. Matsumoto, S. Ogawa, M. Otsuka, K. Hayashi, B. Weiss, C. June, and R. Abe. 2001. Critical requirement for the membrane-proximal tyrosine residue for CD28-mediated costimulation in vivo. J. Immunol. 166: 3797-3803.
73. Okkenhaug, K., L. Wu, K. Garza, J. La Rose, W. Khoo, B. Odermatt, T. Mak, P. Ohashi, and R. Rottapel. 2001. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat. Immunol. 2: 325-332.
74. Ragheb, J. A., M. Deen, and R. Schwartz. 1999. CD28-mediated regulation of mRNA stability requires sequences within the coding region of the IL-2 mRNA. J. Immunol. 163: 120-129.